In general, the effect of ANXA1 on tumour cells seems to be diverse and sometimes even opposing due to mutations in the gene, hypermethylation of the promoter and subsequent loss of transcription, posttranslational modification of the protein, and defects in protein storage, among others [14]. Here, ANXA1 is linked to neoplasm.